SMARCA4 and brain cancer: Whilst numerous studies have investigated the effects of BRG1 overexpression and knockdown in the context of brain cancer [30, 61, 63, 64], fewer have explored the direct mechanistic consequences that specific point mutations recurrently observed in brain cancer patients have on normal BRG1 function.